行情

MDVL

MDVL

MedAvail Holdings Inc
NASDAQ

实时行情|Nasdaq Last Sale

1.460
+0.060
+4.29%
盘后: 1.500 +0.04 +2.74% 19:52 01/18 EST
开盘
1.450
昨收
1.400
最高
1.470
最低
1.370
成交量
16.18万
成交额
--
52周最高
17.48
52周最低
1.170
市值
4,795.83万
市盈率(TTM)
-0.6739
分时
5日
1月
3月
1年
5年
NXTD, PIXY and VORB among mid-day movers
Gainers: Guardforce AI (NASDAQ:GFAI) +67%. Splash Beverage (NYSE:SBEV) +42%. ShiftPixy (NASDAQ:PIXY) +24%. ATI Physical (NYSE:ATIP) +23%. Vinco Ventures (NASDAQ:BBIG) +18%. Theseus Pharmaceuticals (NASDAQ:THRX) +19%. Indonesia Energy (NYSE:INDO) +16%. Plan...
Seekingalpha · 4天前
ATI Physical, Cardiovascular Systems top healthcare gainers; Acutus, GeoVax among losers
Gainers: ATI Physical Therapy (NYSE:ATIP) +16%. Cardiovascular Systems (NASDAQ:CSII) +14%. Theseus Pharmaceuticals (NASDAQ:THRX) +11%. Molecular Partners (NASDAQ:MOLN) +8%.  Atara Biotherapeutics (NASDAQ:ATRA) +5%. Losers: Acutus Medical (NASDAQ:AFIB) -9%....
Seekingalpha · 4天前
BRIEF-Medavail Announces Changes To Executive Management And Board Of Directors Preliminary Fourth Quarter And FY 2021 Results
reuters.com · 01/11 22:05
MedAvail forecasts 123% net sales growth in Q4
MedAvail Holdings (NASDAQ:MDVL) expects to post Q4 net sales of $6.9M-$7.2M, up 123% from $3.1M in Q4 2020. Net sales for 2021 are expected to be $21.7M-$22M, up over 55%
Seekingalpha · 01/11 21:28
BRIEF-MedAvail And IMA Medical Group Expand Partnership
reuters.com · 01/05 13:29
MedAvail, Altamira Therapeutics leads healthcare gainers; Chembio Diagnostics, Gamida Cell among major losers
Gainers: MedAvail (NASDAQ:MDVL) +17%, Altamira Therapeutics (NASDAQ:CYTO) +17%, Orchard Therapeutics (NASDAQ:ORTX) +10%,Biofrontera (NASDAQ:BFRI) +9%, XORTX Therapeutics (NASDAQ:XRTX) +7%. Losers: Chembio Diagnostics (NASDAQ:CEMI) -16%, Gamida Cell (NASDAQ...
Seekingalpha · 2021/12/29 16:03
BRIEF-Medavail Signs Four Spotrx Locations With Cano Health In California
reuters.com · 2021/11/23 13:56
MedAvail Reports Signed Initial 4 Co. Clinics With Cano Health In California, No Terms Disclosed
MedAvail Holdings, Inc. (NASDAQ:MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, has signed an initial four clinics with Cano Health in California. In-clinic SpotRx kiosks and courier home
Benzinga · 2021/11/23 13:08
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解MDVL最新的财务预测,通过MDVL每股收益,每股净资产,每股现金流等数据分析MedAvail Holdings Inc近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测MDVL价格均价为7.50,最高价位8.00,最低价为7.00。
最高8.00
均价7.50
最低7.00
现价1.460
EPS
实际EPS
预期EPS
-0.57-0.43-0.28-0.14
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 55
机构持股: 2,689.44万
持股比例: 81.88%
总股本: 3,284.82万
类型机构数股数
增持
18
45.12万
建仓
12
42.09万
减持
4
117.02万
平仓
8
123.84万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
工业机械及设备
-0.99%
Machinery, Tools, Heavy Vehicles, Trains & Ships
-1.19%
高管信息
Chairman/Director
Robert Faulkner
Chief Executive Officer/Director
Mark Doerr
Chief Financial Officer/Controller
Brian Schlerf
Chief Financial Officer
Ramona Seabaugh
Corporate Executive
Joan O'Rourke
Chief Marketing Officer
Will Misloski
Other
Neil Prezioso
Other
Dave Rawlins
Director
Paul Johnson
Director
Laurie McGraw
Independent Director
Gerald Gradwell
Independent Director
Michael Kramer
Independent Director
Glen Stettin
暂无数据
MDVL 简况
MedAvail Holdings Inc(MedAvail)是一家支持远程医疗的药房技术公司。该公司开发药房、移动应用程序、信息亭和直通车解决方案并将其商业化。MedAvail 的主要技术和产品是 MedCenter,这是一个药剂师控制的、客户交互的处方配药系统,类似于盒装药房或处方配药自动柜员机 (ATM)。MedCenter通过双向音频-视频通信促进现场药剂师咨询,并能够在药剂师的控制下分配处方药。MedAvail 还经营 SpotRx(药房),这是一家利用公司自动化药房技术的全方位服务零售药房。该公司的部门包括零售药房服务部门和药房技术部门。

微牛提供Medavail Holdings Inc(NASDAQ-MDVL)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的MDVL股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易MDVL股票基本功能。